Our results similarly demonstrated that CDKN2B‐AS1 transcripts in PCa were higher compared to noncancerous tissues in the TCGA‐PRAD dataset and were associated with advanced T and N stages, higher Gleason scores and poor prognostic outcomes. The gene discussed is CDKN2B; the disease is prostate adenocarcinoma.